AI assistant
ARTIVION, INC. — Director's Dealing 2020
Feb 25, 2020
31684_dirs_2020-02-25_fed1a9f4-1e35-4618-8a94-8dc736989e98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2020-02-21
Reporting Person: Capps Scott B (VP, Clinical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-21 | Common Stock | F | 1510 | $26.20 | Disposed | 145561 | Direct |
| 2020-02-21 | Common Stock | A | 1998 | — | Acquired | 147559 | Direct |
| 2020-02-21 | Common Stock | F | 292 | $26.2 | Disposed | 147267 | Direct |
Footnotes
F1: Represent shares of restricted stock that were withheld for taxes on the grant vest date.
F2: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date.
F3: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.